Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Bookmark | Print | E-Mail

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic e-mail notifications as soon as a clinical trial is posted in the medical category you're interested in.






Home » Drug Information » FDA-Approved Drugs » 1999
Medical Areas: Pediatrics/Neonatology

View By: Year Company Therapeutic Areas Drug Names 

Drug Information

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Drug Name: Amoxil (amoxicillin)

Company: SmithKline Beecham
Approval Status: Approved July 1999
Treatment Area: Pediatrics

General Information

Amoxil, previously given three times a day to pediatric patients, is now available for twice daily dosing. Eliminating the middle dose will make it easier for patients to administer the medicine, as they will no longer have to worry about whether that dose will be given during daycare or school hours. Studies show that, among all types of medications, compliance is generally improved by decreasing the required number of daily doses.

Amoxil is highly active in vitro against Step. Pneumoniae and other common bacteria. It is used primarily as a first-line antibiotic for upper and lower respiratory tract infections. Amoxil can be taken with or without food.

Side Effects

Adverse events include diarrhea and nausea. Amoxil is contraindicated in patients with a history of allergic reaction to any of the penicillins.


Jobson Medical Information

Copyright © 1995-2009 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.